SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Da-Guang Wang, Ya-Bin Sun, Fei Ye, Wei Li, Punyaram Kharbuja, Ling Gao, David Y. Zhang, Jian Suo, Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells, Molecular and Cellular Biochemistry, 2014, 386, 1-2, 143

    CrossRef

  2. 2
    Juliana Poglia Carini, Fábio Klamt, Valquiria Linck Bassani, Flavonoids from Achyrocline satureioides: promising biomolecules for anticancer therapy, RSC Adv., 2014, 4, 7, 3131

    CrossRef

  3. 3
    Yu Li, Xiaoqiang Huang, Zhiqiang Huang, Jian Feng, Phenoxodiol Enhances the Antitumor Activity of Gemcitabine in Gallbladder Cancer Through Suppressing Akt/mTOR Pathway, Cell Biochemistry and Biophysics, 2014, 70, 2, 1337

    CrossRef

  4. 4
    Gopinath Gudipudi, Someswar R. Sagurthi, Shyam Perugu, G. Achaiah, G. L. David Krupadanam, Rational design and synthesis of novel 2-(substituted-2H-chromen-3-yl)-5-aryl-1H-imidazole derivatives as an anti-angiogenesis and anti-cancer agent, RSC Adv., 2014, 4, 99, 56489

    CrossRef

  5. 5
    C. Fotopoulou, I. Vergote, P. Mainwaring, M. Bidzinski, J. B. Vermorken, S. A. Ghamande, P. Harnett, S. A. Del Prete, J. A. Green, M. Spaczynski, S. Blagden, M. Gore, J. Ledermann, S. Kaye, H. Gabra, Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, 2014, 25, 1, 160

    CrossRef

  6. 6
    Yiwei Li, Dejuan Kong, Aamir Ahmad, Bin Bao, Fazlul H. Sarkar, Antioxidant Function of Isoflavone and 3,3′-Diindolylmethane: Are They Important for Cancer Prevention and Therapy?, Antioxidants & Redox Signaling, 2013, 19, 2, 139

    CrossRef

  7. 7
    David J. Pinato, Janet Graham, Hani Gabra, Rohini Sharma, Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance, Cancer Treatment Reviews, 2013, 39, 2, 153

    CrossRef

  8. 8
    Vinicius Craveiro, Yang Yang-Hartwich, Jennie C. Holmberg, Natalia J. Sumi, John Pizzonia, Brian Griffin, Sabrina K. Gill, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Ayesha B. Alvero, Gil Mor, Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment, Cancer Medicine, 2013, 2, 6
  9. 9
    Nicole A. Doudican, Sara A. Byron, Pamela M. Pollock, Seth J. Orlow, XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts, Anti-Cancer Drugs, 2013, 24, 2, 181

    CrossRef

  10. 10
    Yiwei Li, Dejuan Kong, Aamir Ahmad, Bin Bao, Fazlul Sarkar, Inflammation, Oxidative Stress, and Cancer, 2013,

    CrossRef

  11. 11
    Simon Mahoney, Frank Arfuso, Pierra Rogers, Susan Hisheh, David Brown, Michael Millward, Arun Dharmarajan, Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines, Journal of Biosciences, 2012, 37, 1, 73

    CrossRef

  12. 12
    Kang Cao, Jing Yang, Chao Lin, Bao-ning Wang, Yuan Yang, Jing Zhang, Jun Dai, Lei Li, Chun-lai Nie, Zhu Yuan, Ming-yuan Li, NoxaEnhances the Cytotoxic Effect of Gemcitabine in Human Ovarian Cancer Cells, Cancer Biotherapy & Radiopharmaceuticals, 2012, 27, 4, 259

    CrossRef

  13. 13
    Dong Soo Suh, Jong Kil Joo, Seung Chul Kim, Dong Hyung Lee, Woo Hee Yi, Man Soo Yoon, Ki Hyung Kim, Apoptotic effect of NV-196, an isofl avone derivative, in epithelial ovarian cancer cells, Korean Journal of Obstetrics, 2011, 54, 2, 86

    CrossRef

  14. 14
    Victor Okoh, Alok Deoraj, Deodutta Roy, Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011, 1815, 1, 115

    CrossRef

  15. 15
    Michael G. Kelly, Gil Mor, Alan Husband, David M. O'Malley, Lisa Baker, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers, International Journal of Gynecological Cancer, 2011, 21, 4, 633

    CrossRef

  16. 16
    Aliza L. Leizer, Ayesha B. Alvero, Han Hsuan Fu, Jennie C. Holmberg, Yung-Chi Cheng, Dan-Arin Silasi, Thomas Rutherford, Gil Mor, Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells, American Journal of Reproductive Immunology, 2011, 65, 4
  17. 17
    Paul L De Souza, Pamela J Russell, John H Kearsley, Laurence G Howes, Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer, Nutrition Reviews, 2010, 68, 9
  18. 18
    Martin F. Aguero, Marina Venero, David M. Brown, Mark E. Smulson, Luis A. Espinoza, Phenoxodiol inhibits growth of metastatic prostate cancer cells, The Prostate, 2010, 70, 11
  19. 19
    Thomas De Luca, Dorothy M. Morré, D. James Morré, Reciprocal Relationship Between Cytosolic NADH and ENOX2 Inhibition Triggers Sphingolipid-Induced Apoptosis in HeLa Cells, Journal of Cellular Biochemistry, 2010, 110, 6
  20. 20
    R A C McPherson, P T Galettis, P L de Souza, Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells, British Journal of Cancer, 2009, 100, 4, 649

    CrossRef

  21. 21
    R Sharma, J Graham, H Mitchell, A Brooks, S Blagden, H Gabra, Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer, British Journal of Cancer, 2009, 100, 5, 707

    CrossRef

  22. 22
    Ayesha B. Alvero, Michele K. Montagna, Rui Chen, Ki Hyung Kim, Kim Kyungjin, Irene Visintin, Han-Hsuan Fu, David Brown, Gil Mor, NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway, Cancer, 2009, 115, 14
  23. 23
    Sylvianna Georgaki, Margarita Skopeliti, Marinos Tsiatas, Katerina A. Nicolaou, Kyriaki Ioannou, Alan Husband, Aristotelis Bamias, Meletios A. Dimopoulos, Andreas I. Constantinou, Ourania E. Tsitsilonis, Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo, Journal of Cellular and Molecular Medicine, 2009, 13, 9b
  24. 24
    Ayesha B. Alvero, Han-Hsuan Fu, Jennie Holmberg, Irene Visintin, Liora Mor, Carlos Cano Marquina, Jessica Oidtman, Dan-Arin Silasi, Gil Mor, Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors, STEM CELLS, 2009, 27, 10
  25. 25
    Sie-Rong Li, Po-Yuan Chen, Liang-Yeu Chen, Yi-Fang Lo, Ian-Lih Tsai, Eng-Chi Wang, Synthesis of haginin E, equol, daidzein, and formononetin from resorcinol via an isoflavene intermediate, Tetrahedron Letters, 2009, 50, 18, 2121

    CrossRef

  26. 26
    Ayesha B Alvero, Michael Kelly, Patti Rossi, Aliza Leiser, David Brown, Thomas Rutherford, Gil Mor, Anti-tumor activity of phenoxodiol: from bench to clinic, Future Oncology, 2008, 4, 4, 475

    CrossRef

  27. 27
    R Chen, A B Alvero, D-A Silasi, K D Steffensen, G Mor, Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells, Oncogene, 2008, 27, 2, 225

    CrossRef

  28. 28
    Thomas De Luca, Dorothy M. Morré, Elena Bosneaga, D. James Morré, Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol, BioFactors, 2008, 34, 3
  29. 29
    Sanjeev Banerjee, Yiwei Li, Zhiwei Wang, Fazlul H. Sarkar, Multi-targeted therapy of cancer by genistein, Cancer Letters, 2008, 269, 2, 226

    CrossRef

  30. 30
    Rui Chen, Ayesha B. Alvero, Dan-Arin Silasi, Gil Mor, Inflammation, Cancer and Chemoresistance: Taking Advantage of the Toll-Like Receptor Signaling Pathway, American Journal of Reproductive Immunology, 2007, 57, 2
  31. 31
    Rinki Agarwal, Dong Hee Whang, Ayesha B. Alvero, Irene Visintin, Yinglei Lai, Elliot A. Segal, Peter Schwartz, David Ward, Thomas Rutherford, Gil Mor, Macrophage migration inhibitory factor expression in ovarian cancer, American Journal of Obstetrics and Gynecology, 2007, 196, 4, 348.e1

    CrossRef

  32. 32
    Hao Lin, Chan-Chao Changchien, Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches, Taiwanese Journal of Obstetrics and Gynecology, 2007, 46, 4, 379

    CrossRef

  33. 33
    Kader Yagiz, Lion-Ying Wu, Charles P. Kuntz, D. James Morré, Dorothy M. Morré, Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype, Journal of Cellular Biochemistry, 2007, 101, 2
  34. 34
    Fazlul H SARKAR, Yi-wei LI, Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy, Acta Pharmacologica Sinica, 2007, 28, 9
  35. 35
    P.M. Herst, T. Petersen, P. Jerram, J. Baty, M.V. Berridge, The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells, Biochemical Pharmacology, 2007, 74, 11, 1587

    CrossRef

  36. 36
    Fu Yu, Ralph N. Watts, Xu Dong Zhang, Jodie M. Borrow, Peter Hersey, Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells, Anti-Cancer Drugs, 2006, 17, 10, 1151

    CrossRef